Incorporating founder virus information in vaccine field trials

By Follmann Dean   Huang Chiung-Yu  

Biometrics, Vol. 71, Iss. 2, 2015-06 ,pp. : 386-396

Wiley-Blackwell

Access to resources Recommend Favorite

Evidence for a Founder Effect After Introduction of Tomato Yellow Leaf Curl Virus–Mild in an Insular Environment

By Delatte Hélène   Holota Hélène   Moury Benoit   Reynaud Bernard   Lett Jean-Michel   Peterschmitt Michel  

Journal of Molecular Evolution, Vol. 65, Iss. 1, 2007-07 ,pp. : 112-118

Springer Publishing Company

Access to resources Recommend Favorite

A serum-free Vero production platform for a chimeric virus vaccine candidate

By Yuk Inn   Lin Gina   Ju Hui   Sifi Inesse   Lam Yvonne   Cortez Armida   Liebertz Danny   Berry J.   Schwartz Richard  

Cytotechnology, Vol. 51, Iss. 3, 2006-07 ,pp. : 183-192

Springer Publishing Company

Access to resources Recommend Favorite

Robust meta-analytic-predictive priors in clinical trials with historical control information

By Schmidli Heinz   Gsteiger Sandro   Roychoudhury Satrajit   O'Hagan Anthony   Spiegelhalter David   Neuenschwander Beat  

Biometrics, Vol. 70, Iss. 4, 2014-12 ,pp. : 1023-1032

Wiley-Blackwell

Access to resources Recommend Favorite

A microcarrier-based cell culture process for the production of a bovine respiratory syncytial virus vaccine

By Moran Enda  

Cytotechnology, Vol. 29, Iss. 2, 1999-03 ,pp. : 135-149

Springer Publishing Company

Access to resources Recommend Favorite